Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Quality of surveillance in patients with completely resected gastroenteropancreatic neuroendocrine tumors.
Authors
Gordon Taylor Moffat
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
Gordon Taylor Moffat , Aruz Mesci , Sami A. Chadi , Raymond Woo-Jun Jang , Lisa Avery , Carol-Anne Moulton , Paul C. Nathan , Monika K. Krzyzanowska
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 591)
DOI
10.1200/JCO.2024.42.3_suppl.591
Abstract #
591
Poster Bd #
H2
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Multi-target blood test to improve the performance of hepatocellular carcinoma surveillance programs: A modeling-based virtual trial.
First Author: Jagpreet Chhatwal
Poster
2024 ASCO Genitourinary Cancers Symposium
Underutilization of androgen deprivation therapy (ADT) intensification for the treatment of men with metastatic hormone-sensitive prostate cancer (mHSPC): A systematic review of real-world database studies.
First Author: Amit D Raval
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.
First Author: Alok Tewari
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Surveillance of resected metastatic colorectal cancer utilizing circulating DNA.
First Author: Nikolas Naleid